BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2018
View Archived Issues
Cleaning up synuclein
Read More
Crystal structure of Pseudomonas exotoxins and human 14-3-3 protein identifies a new target
Read More
ASM opens BBB in aging
Read More
Preclinical results presented for novel 6-amino-6-deoxy paramylon for the treatment of obesity
Read More
Novel anti-inflammatory CXCL12 neutraligand with improved characteristics discovered
Read More
Nilvadipine does not demonstrate efficacy in patients with mild to moderate Alzheimer's disease
Read More
Novel Janssen hepatitis B virus capsid assembly modulators possess potent antiviral activity
Read More
Hemispherx and Roswell Park enter clinical trial agreement to study Ampligen
Read More
U.S. DoD funding phase II combination study of TPIV-110 in breast cancer
Read More
Helix BioPharma, Moffitt Cancer Center expand collaboration
Read More
The nitty gritty: Drilling down into sepsis shows routes to treatment
Read More
Urinary exosomal CCL-21 mRNA as marker of histological injury and renal function deterioration in DN
Read More
PF-06939926 induces a greater amelioration of DMD pathology when administered at a younger age
Read More
GS-6207 shows long-acting nonclinical pharmacokinetic profile
Read More
R-DMDdel52, a new rat model of Duchenne muscular dystrophy, developed
Read More
Hypermethylation of miR-145-5p drives laryngeal squamous cell carcinoma invasion and metastasis
Read More
Chinese researchers patent adenosine A2A receptor antagonists
Read More
Gedeon Richter presents GABA-B receptor PAMs
Read More
New phase II/III trial in Brazil studies meningococcus C vaccine MenCC-Bio
Read More
Genentech and Roche identify MAP4K1 inhibitors
Read More
Cognition Therapeutics begins phase II trial of CT-1812 in mild to moderate Alzheimer's disease
Read More
Cardio Therapeutics patent describes PCSK9 inhibitors
Read More
Galera initiates phase III study of GC-4419 to reduce radiation-induced oral mucositis
Read More
Athenex discloses CRAC modulators as IL-2 production inhibitors
Read More
Perjeta approved in Japan for neoadjuvant and adjuvant use in HER2-positive early breast cancer
Read More
ASSESS trial demonstrates superior efficacy of Gilenya over Copaxone in relapsing-remitting MS
Read More
Ritter presents additional phase IIb data on RP-G28 for treatment of lactose intolerance
Read More
Stelara induces clinical remission and response in moderate to severe ulcerative colitis
Read More
Pharmaxis reports phase I data for first LOXL2 inhibitor
Read More